statistiche ricercatore

Continente	#
EU - Europa	2.909
NA - Nord America	875
AS - Asia	828
AF - Africa	52
SA - Sud America	42
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	4.708

Nazione	#
NL - Olanda	1.970
US - Stati Uniti d'America	866
DE - Germania	446
VN - Vietnam	314
SG - Singapore	188
CN - Cina	139
GB - Regno Unito	105
SE - Svezia	103
IT - Italia	82
HK - Hong Kong	72
FR - Francia	39
UA - Ucraina	37
RU - Federazione Russa	36
BR - Brasile	31
IN - India	29
FI - Finlandia	24
JP - Giappone	20
IE - Irlanda	19
TG - Togo	19
KR - Corea	15
ZA - Sudafrica	13
EE - Estonia	10
BD - Bangladesh	9
PL - Polonia	9
CI - Costa d'Avorio	8
TR - Turchia	8
NG - Nigeria	7
BG - Bulgaria	6
CA - Canada	6
PH - Filippine	6
AR - Argentina	5
BE - Belgio	5
CH - Svizzera	4
ID - Indonesia	4
IR - Iran	4
TH - Thailandia	4
ES - Italia	3
HR - Croazia	3
JO - Giordania	3
LB - Libano	3
MX - Messico	3
TW - Taiwan	3
CL - Cile	2
EC - Ecuador	2
GR - Grecia	2
KE - Kenya	2
MY - Malesia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AU - Australia	1
BY - Bielorussia	1
DZ - Algeria	1
ET - Etiopia	1
HU - Ungheria	1
IL - Israele	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
LV - Lettonia	1
NO - Norvegia	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
SA - Arabia Saudita	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	4.708

Nome	#
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years	2.843
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.	253
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience	242
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients	239
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.	222
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study	216
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.	204
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients	197
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.	174
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.	148
Totale	4.738

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	150	0	0	0	0	0	0	0	0	0	0	11	139
2021/2022	308	76	11	17	29	18	12	6	13	7	22	54	43
2022/2023	319	41	59	25	48	15	34	5	17	35	5	17	18
2023/2024	82	9	14	3	11	6	17	7	1	0	7	2	5
2024/2025	363	10	21	13	20	56	12	47	7	9	38	13	117
2025/2026	2.963	44	50	51	25	89	1.339	1.115	11	175	46	18	0
Totale													4.738

CRIS Current Research Information System